Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
11/17/2011 | US20110280955 Nutritional Supplements For 50+ Individuals For Improving Vitality, Immunity, Eye And Bone Health |
11/17/2011 | US20110280935 Viral and non-viral vectors as vehicles for delivering transgenes for treating bone pathologies |
11/17/2011 | US20110280932 Sustained release formulation of methotrexate as a disease-modifying antirheumatic drug (dmard) and an anti-cancer agent |
11/17/2011 | US20110280924 Biodegradable filler for restoration of alveolar bones |
11/17/2011 | US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics |
11/17/2011 | US20110280878 Substance specific to human pd-1 |
11/17/2011 | US20110280876 Mutated netrin - 4, fragments thereof and their use as medicines |
11/17/2011 | US20110280873 MCP1-Ig FUSION VARIANTS |
11/17/2011 | US20110280871 Methods for prevention and treatment of inflammation using anti-chemokine antibodies |
11/17/2011 | US20110280866 Anti-cd 160 monoclonal antibodies and uses thereof |
11/17/2011 | US20110280855 Vitamin c compositions |
11/17/2011 | US20110280848 Composition comprising chicoric acid and/or derivatives thereof |
11/17/2011 | US20110280845 Treatment of rheumatoid arthritis using placental stem cells |
11/17/2011 | US20110280841 Electroprocessing in Drug Delivery and Cell Encapsulation |
11/17/2011 | US20110280840 Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
11/17/2011 | US20110280838 Treatment of intervertebral disc degeneration using human umbilical cord tissue-derived cells |
11/17/2011 | US20110280832 Eotaxin-2 (ccl24) inhibitors in inflammatory, autoimmune, and cardiovascular disorders |
11/17/2011 | US20110280831 Combinations comprising methotrexate and dhodh inhibitors |
11/17/2011 | US20110280830 Albumin Fusion Proteins |
11/17/2011 | US20110280829 Low Molecular Weight Sulphated Polysaccharides as Candidates for Anti-Angiogenic Therapy |
11/17/2011 | US20110280800 Il-1 binding proteins |
11/17/2011 | US20110280799 Nanocells for diagnosis and treatment of diseases and disorders |
11/17/2011 | DE102010020567A1 Metallkomplexe Metal complexes |
11/17/2011 | CA2835596A1 Benzo- or pyrido-imidazole derivative |
11/17/2011 | CA2799168A1 Methods of control and prophylaxis of inflammation and mitigation of inflammatory conditions in companion animals |
11/17/2011 | CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine |
11/17/2011 | CA2798957A1 Lactoferrin-based biomaterials for tissue regeneration and drug delivery |
11/16/2011 | EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response |
11/16/2011 | EP2386546A1 Novel pyrazole-3-carboxamide derivate having 5-ht2b receptor antagonist activity |
11/16/2011 | EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors |
11/16/2011 | EP2386306A1 Pharmaceutical agent having long-lasting effect of treating arthritic disorders |
11/16/2011 | EP2386305A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues |
11/16/2011 | EP2386304A2 Selective Estrogen Receptor Modulator in Combination With Dehydroepiandrosterone (DHEA) or Analogues |
11/16/2011 | EP2225243B1 Derivatives of N-heterocyclic-6-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof |
11/16/2011 | EP1931676B1 Pyrazolopyrimidines as protein kinase inhibitors |
11/16/2011 | EP1885751B1 Bone morphogenetic protein 6 containing a heparin binding site and osteogenic devices and pharmaceutical products containing thereof |
11/16/2011 | EP1605963B1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
11/16/2011 | CN202036382U Collar for treating cervical spondylosis |
11/16/2011 | CN102245587A Trpv1 antagonists |
11/16/2011 | CN102245205A Methods to reduce B-helper T cells to treat autoimmune diseases |
11/16/2011 | CN102242152A Humic acid active component and preparation method, application and pharmaceutical composition thereof |
11/16/2011 | CN102241776A RANKL-TNF (Receptor Activator of Nuclear Factor Kappa-B Ligand-Tumour Necrosis Factor) sample region fusion protein and preparation method and application thereof |
11/16/2011 | CN102241773A Anti-myeloma cell polyclonal antibody and preparation method thereof |
11/16/2011 | CN102241733A Deer ossein polypeptide chelated calcium and enteric capsule and preparation method of enteric capsule |
11/16/2011 | CN102241680A Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
11/16/2011 | CN102241657A Synthesis of isoflavone compound through Stille crossed coupling reaction |
11/16/2011 | CN102241621A 5,5-disubstituted-2-iminopyrrolidine derivatives, preparation method thereof, and medical applications thereof |
11/16/2011 | CN102240391A Traditional Chinese medicine solution for health promotion |
11/16/2011 | CN102240389A Medicament for treating arthralgia due to wind-cold-dampness |
11/16/2011 | CN102240388A Ginger extract and preparation method and applications thereof |
11/16/2011 | CN102240378A Pharmaceutical composition for treating gout and preparation method thereof |
11/16/2011 | CN102240372A Medicine for treating gouty arthritis and hyperuricemia and preparation method thereof |
11/16/2011 | CN102240367A Blood circulation promoting and vein relaxing preparation |
11/16/2011 | CN102240356A Powder for treating cervical spondylosis, intervertebral disc herniation, ankylosing spondylitis and hyperosteogeny |
11/16/2011 | CN102240351A Traditional Chinese medicine for treating Arthritis, hyperosteogeny, cervical disc herniation and cervical spondylosis |
11/16/2011 | CN102240350A Composition for treating gout and preparation method thereof |
11/16/2011 | CN102240347A Pharmaceutical composition for treating hyperuricemia and preparation method thereof |
11/16/2011 | CN102240331A Ointment mainly for treating rheumatoid arthritis |
11/16/2011 | CN102240330A Medicinal composition for strengthening bones |
11/16/2011 | CN102240321A Medicinal composition for treating bone infarction and preparation method and application thereof |
11/16/2011 | CN102240317A Extraction process for preparing total flavones and chlorogenic acid from traditional Chinese medicine eucommia leaf |
11/16/2011 | CN102240306A Process for extracting proanthocyanidins from pine cone shells |
11/16/2011 | CN102240300A Method for producing biologically active products |
11/16/2011 | CN102240278A Methods, assays and compositions for treating retinol-related diseases |
11/16/2011 | CN102240264A Application of poly(cinnamic alcohol) injection used as cyst treatment medicament |
11/16/2011 | CN102240125A Nerve-soothing tendon-relaxing neck pillow |
11/16/2011 | CN102240037A Amino acid and calcium composite powder |
11/16/2011 | CN102240034A Combination with functions of increasing bone density and preventing osteoporosis |
11/16/2011 | CN102028921B Externally applied plaster prepared from pure traditional Chinese medicines and preparation method thereof |
11/16/2011 | CN102018769B Radix gentianae macrophyllae and snake wine for dispelling wind and dredging channels and preparation method thereof |
11/16/2011 | CN102008674B Plaster for treating herniated disk, hyperosteogeny and rheumatoid diseases and preparation method thereof |
11/16/2011 | CN101972287B Preparation method of Chinese astilbe extract and purpose thereof |
11/16/2011 | CN101953926B Oral Chinese medicinal composition for treating gout |
11/16/2011 | CN101884665B Traditional Chinese medicine extract with alpha-glucuroide and xanthine oxidase inhibiting effect and preparation method and usage thereof |
11/16/2011 | CN101810756B Plaster for treating lumbar |
11/16/2011 | CN101797327B Chinese medicinal preparation for treating pain caused by orthopedic diseases |
11/16/2011 | CN101732464B Chinese medicinal health-care wine for treating scapulohumeral periarthritis |
11/16/2011 | CN101676401B Scorpion extract |
11/16/2011 | CN101648926B Febuxostat crystal form and preparation method thereof |
11/16/2011 | CN101646433B Anti-resorptive and bone building dietary supplements and methods of use |
11/16/2011 | CN101618082B Medicated wine for curing waist and leg aches and prolepses of lumbar intervertebral |
11/16/2011 | CN101543563B Vein-relaxing bone-nourishing osteophyte-eliminating ointment and method for preparing same |
11/16/2011 | CN101524450B Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof |
11/16/2011 | CN101407812B Heterologous expression and purification method for human RANTES protein having chemotaxis |
11/16/2011 | CN101293082B Anti-heart failure pharmaceutical composition for improving skeletal muscle function and preparation method thereof |
11/16/2011 | CN101068826B Potent LNA oligonucleotides for the inhibition of HIF-1A expression |
11/15/2011 | US8058426 Phosphorus-containing compounds and uses thereof |
11/15/2011 | US8058418 Polynucleotides encoding heavy and light chains of antibodies to OPGL |
11/15/2011 | US8058400 Composition and method for modulating dendritic cell-t cell interaction |
11/15/2011 | US8058344 Glycodendrimers having biological activity |
11/15/2011 | US8058305 Pyrrolidine derivatives as prostaglandin modulators |
11/15/2011 | US8058282 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds and compositions for use in therapy |
11/15/2011 | US8058249 Immunostimulatory nucleic acid molecules |
11/15/2011 | US8058245 Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
11/15/2011 | US8057825 Krill extracts for treatment of cardiovascular diseases |
11/15/2011 | US8057789 Hematopoietic stem cell culture for use in treatment of blood disorders; regenerative medicine; tissue engineering |
11/15/2011 | CA2479126C Combination treatments for chemokine-mediated diseases |
11/15/2011 | CA2461989C Method for treating multiple myeloma |
11/15/2011 | CA2449403C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria |
11/15/2011 | CA2429979C Treatment of statin side effects |